arrow_back Back to App

Boosting Brain Tumor Research and Care Improvement Act

This act aims to accelerate research into brain tumors, including glioblastoma, and enhance access to specialized care. Citizens can expect improved access to information about clinical trials and new treatments, as well as support for brain tumor survivors.
Key points
Increased transparency in sharing tumor tissue samples for research, speeding up discoveries.
Establishment of a glioblastoma research network and support for cellular therapies, potentially leading to new drugs.
Nationwide public awareness campaign on clinical trials and biomarker testing, increasing patient knowledge.
Pilot programs for better care and monitoring of brain tumor survivors, improving quality of life.
FDA guidance to facilitate brain tumor patients' access to clinical trials.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_S_1330
Sponsor: Sen. Blumenthal, Richard [D-CT]
Process start date: 2025-04-08
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

BRAIN Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_S_1330.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-04-08.

What are the main provisions?

Key points include:

  • Increased transparency in sharing tumor tissue samples for research, speeding up discoveries.
  • Establishment of a glioblastoma research network and support for cellular therapies, potentially leading to new drugs.
  • Nationwide public awareness campaign on clinical trials and biomarker testing, increasing patient knowledge.
  • Pilot programs for better care and monitoring of brain tumor survivors, improving quality of life.
  • FDA guidance to facilitate brain tumor patients' access to clinical trials.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Blumenthal, Richard [D-CT].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health